Calendar Cidara Therapeutics, Inc.

Equities

CDTX

US1717571079

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
0.92 USD +9.25% Intraday chart for Cidara Therapeutics, Inc. +14.56% +15.87%

Chart calendar Cidara Therapeutics, Inc.

0.QB9B4AxoKvc4Z2oHvKBA3qgP2IMVoHJmWepfy3MXono.OkhxkD5FbY1hVRBAzY0Hsfw-scZekiMDLNg0ohhPz044ZjXWayBaunURHQ~e8ecdd7333ac1ae3417cefad4bba5699

Upcoming events on Cidara Therapeutics, Inc.

2024-04-04 11:00 am Extraordinary Shareholders Meeting
2024-04-08 12:00 pm American Association for Cancer Research Meeting - Elizabeth Abelovski
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Simon Döhrmann
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Amanda Almaguer
2024-04-08 04:30 pm American Association for Cancer Research Meeting - James Levin
2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)

Past events on Cidara Therapeutics, Inc.

2024-02-27 Q4 2023 Earnings Release (Projected)
2023-12-07 06:00 am European Society for Medical Oncology Immuno Oncology Congress - Discovery of a Novel, Dual CD73 & P
2023-12-07 06:00 am European Society for Medical Oncology Immuno Oncology Congress - Discovery of CBO421, a First-in-Cla
2023-11-03 03:00 pm Society for Immunotherapy of Cancer Meeting
2023-11-02 04:15 pm Q3 2023 Earnings Release
2023-10-14 12:15 pm IDWeek Conference - James Levin
2023-10-14 12:15 pm IDWeek Conference - Shawn Flanagan
2023-10-14 10:30 am IDWeek Conference - James Levin
2023-09-21 12:00 pm R&D Day
2023-09-11 10:00 am H.C. Wainwright Global Investment Conference
2023-08-03 04:08 pm Q2 2023 Earnings Release
2023-06-22 11:00 am Annual General Meeting
2023-06-22 09:30 am Adenosine Pathway Targeted Cancer Immunotherapy Summit
2023-05-11 04:37 pm Q1 2023 Earnings Release
2023-05-04 02:35 pm International Society for Influenza and Respiratory Virus Diseases Conference
2023-05-03 05:30 pm International Society for Influenza and Respiratory Virus Diseases Conference
2023-04-17 12:45 pm Needham Healthcare Conference
2023-04-03 11:00 am Cantor The Future of Oncology Virtual Symposium - Panel
2023-03-23 07:12 am Q4 2022 Earnings Release
2023-03-06 11:35 am ESMO Targeted Anticancer Therapies Congress - Presentation Number: 45P

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
20,9
17,1
22.67%
12,1
18,5
-34.89%
49,6
46,6
6.28%
64,3
64,7
-0.62%

57,8

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-63,3
-63,7
0.58%
-41,7
-47,4
11.9%
-71,8
-60,9
-17.92%
-42,3
-47,1
10.21%
-29,7
-28,4
-4.82%

-28,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-59,0
-67,0
11.87%
-41,1
-41,9
2.04%
-72,1
-61,1
-18.06%
-42,5
-47,5
10.66%
-29,5
-28,3
-4.37%

-26,3

Net income
Million USD
Released
Forecast
Spread
-69,3
-70,4
1.54%
-41,1
-42,1
2.42%
-74,9
-62,4
-19.9%
-42,5
-47,9
11.39%
-29,8
-30,4
1.82%

-27,4

EPS
USD
Released
Forecast
Spread
-2,76
-2,96
6.66%
-1,41
-1,38
-1.84%
-1,80
-1,55
-16.5%
-0,81
-0,88
8.3%
-0,43
-0,42
-3.2%

-0,31

Announcement Date28/02/1904/03/2025/02/2107/03/2223/03/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
7,08
2,94
140.5%
7,23
4,31
67.62%
7,11
4,71
50.86%
6,22
4,97
25.2%
40,7
22,7
79.67%
10,2
10,6
-3.29%
26,0
18,7
39.11%
7,61
11,5
-34.06%
12,7
8,14
56.25%

11,5


13,1


6,95


4,20


5,71

EBIT
Million USD
Released
Forecast
Spread
-18,0
-20,0
9.84%
-16,8
-21,6
22.25%
-18,3
-19,2
4.75%
-13,1
-19,3
32.06%
14,9
5,83
156.13%
-13,3
-11,9
-11.49%
2,98
-3,28
190.67%
-12,8
-12,4
-3.31%
-8,56
-15,2
43.68%

-9,86


-6,85


-12,8


-16,0


-14,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-18,1
-20,0
9.54%
-16,8
-21,6
22.06%
-18,3
-19,2
4.83%
-13,1
-19,2
31.73%
15,0
5,81
157.63%
-13,1
-11,9
-10.28%
3,21
-3,13
202.42%
-12,2
-12,3
0.51%
-7,94
-13,6
41.51%

-9,53


-6,60


-12,6


-15,8


-14,1

Net income
Million USD
Released
Forecast
Spread
-18,1
-20,0
9.54%
-16,8
-21,6
22.06%
-18,3
-19,2
4.83%
-13,1
-19,3
32.18%
11,9
5,81
104.64%
-13,4
-11,9
-12.57%
2,53
-3,13
180.81%
-12,4
-12,3
-0.71%
-8,17
-13,6
39.81%

-9,53


-6,60


-12,6


-15,8


-14,1

EPS
USD
Released
Forecast
Spread
-0,37
-0,35
-4.52%
-0,28
-0,33
13.85%
-0,27
-0,28
2.88%
-0,19
-0,28
32.14%
0,17
0,07
151.85%
-0,19
-0,15
-29.54%
0,03
-0,04
181.81%
-0,14
-0,13
-7.69%
-0,09
-0,15
40%

-0,10


-0,07


-0,14


-0,16


-0,14

Announcement Date10/11/2107/03/2211/05/2209/08/2203/11/2223/03/2311/05/2303/08/2302/11/23-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise